By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Development, manufacturing, and sales of testing and diagnostic products in the life science and4.69B100.00%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
Europe2.93B62.48%
Japan1.11B23.71%
Others324.36M6.91%
North America323.61M6.90%
